Banque Pictet & Cie Sa Iovance Biotherapeutics, Inc. Transaction History

Banque Pictet & Cie Sa

$14.2 Billion
Q2 2025

A detailed history of Banque Pictet & Cie Sa transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 62,121 shares of IOVA stock, worth $145,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,121

Previous 66,294 6.29%

Holding current value

$145,363

Previous $220,000 51.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$1.66 - $3.61 $6,927 - $15,064	-4,173 Reduced 6.29%	62,121 $106,000
Q1 2025 Apr 30, 2025	SELL	$3.33 - $7.79 $1.03 Million - $2.42 Million	-310,297 Reduced 82.4%	66,294 $220,000
Q4 2024 Jan 30, 2025	BUY	$7.17 - $12.28 $393,145 - $673,336	54,832 Added 17.04%	376,591 $2.79 Million
Q3 2024 Oct 21, 2024	SELL	$7.28 - $11.9 $2.53 Million - $4.13 Million	-346,891 Reduced 51.88%	321,759 $3.02 Million
Q2 2024 Jul 25, 2024	SELL	$7.78 - $14.19 $161,092 - $293,818	-20,706 Reduced 3.0%	668,650 $5.36 Million
Q1 2024 May 06, 2024	SELL	$7.59 - $17.47 $673,096 - $1.55 Million	-88,682 Reduced 11.4%	689,356 $10.2 Million
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $476,005 - $1.28 Million	144,244 Added 22.76%	778,038 $6.33 Million
Q3 2023 Nov 02, 2023	BUY	$4.44 - $8.79 $442,383 - $875,800	99,636 Added 18.65%	633,794 $2.88 Million
Q2 2023 Aug 04, 2023	SELL	$5.36 - $9.06 $743,592 - $1.26 Million	-138,730 Reduced 20.62%	534,158 $3.76 Million
Q1 2023 May 01, 2023	BUY	$5.53 - $8.22 $587,927 - $873,917	106,316 Added 18.76%	672,888 $4.11 Million
Q4 2022 Feb 06, 2023	SELL	$5.62 - $10.0 $163,204 - $290,400	-29,040 Reduced 4.88%	566,572 $0
Q3 2022 Nov 10, 2022	SELL	$9.53 - $13.11 $845,511 - $1.16 Million	-88,721 Reduced 12.96%	595,612 $5.71 Billion
Q2 2022 Aug 08, 2022	BUY	$6.38 - $18.33 $947,831 - $2.72 Million	148,563 Added 27.73%	684,333 $7.56 Million
Q1 2022 May 04, 2022	BUY	$12.38 - $19.1 $21,466 - $33,119	1,734 Added 0.32%	535,770 $8.92 Million
Q4 2021 Feb 02, 2022	BUY	$16.55 - $27.63 $7.73 Million - $12.9 Million	467,364 Added 700.99%	534,036 $10.2 Million
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $153,683 - $201,109	7,552 Added 12.77%	66,672 $1.64 Million
Q2 2021 Aug 12, 2021	BUY	$16.33 - $33.07 $678,070 - $1.37 Million	41,523 Added 235.97%	59,120 $1.54 Million
Q1 2021 May 11, 2021	BUY	$28.67 - $52.59 $504,505 - $925,426	17,597 New	17,597 $557,000

Others Institutions Holding IOVA

# of Institutions

327

Shares Held

247M

Call Options Held

1.34M

Put Options Held

1.61M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $369M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Iovance Biotherapeutics, Inc. Transaction History